News & Updates

Nucleus Biologics Launches CRAIC™ Formulation Finder, Bringing Conversational AI to Cell Culture Media and Buffer Development

Nucleus Biologics, the leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, announced the launch of...

Applications Now Open for MBC BioLabs Winter Life Science Vendor Showcase

Largest law firm merger in history creates Hogan Lovells Cadwalader

From Day One, firm delivers unparalleled practice, sector, and regional strength across key G20 markets as clients face increasing global...

ProBio’s AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class pan-cancer CAR‑T Program

The University of California, Irvine (UC Irvine) School of Medicine and GlyTR Therapeutics have developed a next‑generation AAV‑mediated CAR T‑cell...

At BIO 2026, industry wrestled with Washington politics, and making AI work better

California: Limitless Possibility Lives Here, For Now.

It started with a conversation. A biochemist and a venture capitalist, talking about what science could do, for medicine, for...

California Life Sciences’ Statement on HHS Clinical Trial Effort

Read CLS President & CEO Mike Guerra’s statement on the Department of Health and Human Services’ coordinated effort to restore...

Avance Clinical Announces Asia Pacific and Mainland China Expansion

Avance Clinical, the Australian-headquartered global Contract Research Organization for biotechs, today announced a significant expansion of its Asia Pacific and...

Biointron Launches RushData, a New Integrated Platform in the Era of AI-Driven Antibody Design

AI-driven antibody discovery is rapidly reshaping how therapeutic antibodies are generated and optimized. Biointron has launched RushData, an integrated high-throughput...